Published in J Intern Med on April 01, 1992
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev (1998) 5.33
Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen. Infect Immun (2002) 1.31
Bronchopulmonary infection with Pseudomonas aeruginosa in patients infected with human immunodeficiency virus. Genitourin Med (1995) 1.10
Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect Immun (2003) 1.07
Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey. Eur J Epidemiol (2000) 1.06
Recurrent intravascular-catheter-related bacteremia caused by Delftia acidovorans in a hemodialysis patient. J Clin Microbiol (2011) 1.05
Urinary tract infection in men with AIDS. Genitourin Med (1994) 1.05
Implanted-port-catheter-related sepsis caused by Acidovorax avenae and methicillin-sensitive Staphylococcus aureus. J Clin Microbiol (2009) 0.86
The Fe(III) and Ga(III) coordination chemistry of 3-(1-hydroxymethylidene) and 3-(1-hydroxydecylidene)-5-(2-hydroxyethyl)pyrrolidine-2,4-dione: novel tetramic acid degradation products of homoserine lactone bacterial quorum sensing molecules. J Inorg Biochem (2011) 0.82
Polymicrobial Bacteremia Involving Comamonas testosteroni. Case Rep Med (2014) 0.79
Pseudomonas aeruginosa causing inflammatory mass of the nasopharynx in an immunocompromised HIV infected patient: A mimic of malignancy. IDCases (2015) 0.75
Delftia acidovorans: A rare pathogen in immunocompetent and immunocompromised patients. Can J Infect Dis Med Microbiol (2015) 0.75
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis (2001) 2.50
Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis (2001) 2.49
Sternal wound infections and use of internal mammary artery grafts. J Thorac Cardiovasc Surg (1991) 1.69
Disseminated human herpesvirus 6 infection in AIDS. Lancet (1993) 1.64
Racial differences in performance of invasive cardiac procedures in a Department of Veterans Affairs Medical Center. J Clin Epidemiol (1997) 1.59
The diagnosis of esophageal candidiasis in patients with acquired immune deficiency syndrome: is endoscopy always necessary? Am J Gastroenterol (1989) 1.54
Stenting of the arterial duct in newborns with duct-dependent pulmonary circulation. Heart (2007) 1.51
Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis. J Infect Dis (1989) 1.48
High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1--associated predominantly sensory polyneuropathy. J Infect Dis (1995) 1.47
Aortic valve replacement for aortic stenosis in persons aged 80 years and over. Am J Cardiol (1991) 1.46
Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression. Br J Pharmacol (2009) 1.45
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study. AIDS (2001) 1.41
Histidine supplements in the treatment of uraemic anaemia. Proc Eur Dial Transplant Assoc (1973) 1.40
Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology (2000) 1.39
The 'cherry buffy-coat syndrome', a cause of decreased platelet yield in platelet concentrates obtained from buffy-coats. Vox Sang (2001) 1.38
Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS (1999) 1.36
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res (1998) 1.36
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts. Infection (2009) 1.33
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS (1997) 1.32
HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet (1986) 1.31
Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother (1986) 1.31
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr (2001) 1.31
Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis (1985) 1.29
Inguino-scrotal hernia of a double district ureter: case report and literature review. Hernia (2005) 1.28
Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol (1985) 1.24
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood (1996) 1.23
AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. AIDS (1992) 1.20
Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol (2001) 1.18
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors. Antimicrob Agents Chemother (2000) 1.17
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals. Antivir Ther (2000) 1.16
Aminoacid loss in peritoneal dialysis. Lancet (1967) 1.11
Doxorubicin/methotrexate/fluorouracil in advanced pancreatic cancer. Lancet (1990) 1.09
Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients. Eur Heart J (1988) 1.08
[Contribution of immunofluorescence tests to the biological diagnosis of hydatidosis]. G Mal Infett Parassit (1966) 1.08
Focal lymphocytic myocarditis in acquired immunodeficiency syndrome (AIDS): a correlative morphologic and clinical study in 26 consecutive fatal cases. J Am Coll Cardiol (1988) 1.07
Prospective study of epidemic delta infection in drug addicts. Prog Clin Biol Res (1983) 1.07
Early results of posterior leaflet folding plasty for mitral valve reconstruction. Ann Thorac Surg (1998) 1.06
Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood (2001) 1.05
Scrotal angiokeratoma (Fordyce): histopathological and ultrastructural findings. Histol Histopathol (1992) 1.05
Ten-year experience with aortic valve replacement in 482 patients 70 years of age or older: operative risk and long-term results. Ann Thorac Surg (1990) 1.04
Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood (1997) 1.04
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect (2006) 1.04
Kaposi's sarcoma and AIDS: frequency of gastrointestinal involvement and its effect on survival. A prospective study in a heterogeneous population. Scand J Gastroenterol (1991) 1.03
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS (2001) 1.03
Minimally invasive versus sternotomy approaches for mitral reconstruction: comparison of intermediate-term results. J Thorac Cardiovasc Surg (2001) 0.99
Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science (1997) 0.99
Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection. AIDS Res Hum Retroviruses (1996) 0.97
Long-term results of mitral valve reconstruction with Carpentier techniques in 148 patients with mitral insufficiency. Circulation (1988) 0.97
Disseminated Rhodococcus equi infection initially presenting as foot mycetoma in an HIV-positive patient. AIDS (1992) 0.97
Cryptococcus neoformans infection in a cohort of Italian AIDS patients: natural history, early prognostic parameters, and autopsy findings. Eur J Clin Microbiol Infect Dis (2001) 0.96
Minimally invasive port access surgery reduces operative morbidity for valve replacement in the elderly. Heart Surg Forum (1999) 0.96
Clinical features of sporadic non-A, non-B hepatitis possibly associated with faecal-oral spread. Lancet (1985) 0.95
Inosiplex in recurrent herpes simplex infections. Lancet (1982) 0.95
Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment. Am J Gastroenterol (1991) 0.95
A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol (1997) 0.94
Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS. AIDS (1997) 0.94
Reorganization of functional connectivity of the language network in patients with brain gliomas. AJNR Am J Neuroradiol (2012) 0.93
HIV-1 infection, tuberculosis, and syphilis in male transsexual prostitutes in Milan, Italy. J Acquir Immune Defic Syndr (1991) 0.93
Fluorescence spectra of DNA dyes measured in a flow cytometer. Cytometry (1996) 0.93
Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group. JAMA (1992) 0.93
CD4 cell counts at the third month of HAART may predict clinical failure. AIDS (1999) 0.93
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART. J Acquir Immune Defic Syndr (2001) 0.92
IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. Br Med J (Clin Res Ed) (1985) 0.92
Simultaneously acquired hepatitis B and hepatitis D virus infections. Br Med J (Clin Res Ed) (1985) 0.91
Prolonged course and relapses of acute type A hepatitis. Boll Ist Sieroter Milan (1984) 0.91
Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS (1996) 0.90
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis. HIV Clin Trials (2004) 0.90
Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration. Science (1977) 0.90
Primary and secondary prevention of atherosclerosis: is there a role for antioxidants? Diabetes Metab (1999) 0.90
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine. J Acquir Immune Defic Syndr (1999) 0.90
Somatic mutation of EGFR catalytic domain and treatment with gefitinib in colorectal cancer. Ann Oncol (2005) 0.90
Diabetic rat testes: morphological and functional alterations. Andrologia (2009) 0.90
Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature. Eur J Epidemiol (1998) 0.89
Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha. J Biol Chem (1999) 0.89
High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication. J Infect Dis (1997) 0.89
In vitro antioxidant properties of amifostine (WR-2721, Ethyol). Cancer Chemother Pharmacol (2000) 0.89
Fluconazole for cryptococcal meningitis. Ann Intern Med (1989) 0.89
Sarcoidosis following beta-interferon therapy for multiple myeloma. Sarcoidosis (1995) 0.89
An atypical form of alphaB-crystallin is present in high concentration in some human cataractous lenses. Identification and characterization of aberrant N- and C-terminal processing. J Biol Chem (1999) 0.88
Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection. AIDS (2000) 0.88
Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab (1992) 0.87
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group. Antimicrob Agents Chemother (2000) 0.87
The effects of different techniques of internal mammary artery harvesting on sternal blood flow. J Thorac Cardiovasc Surg (1992) 0.87
The syndrome of acquired glucocorticoid resistance in HIV infection. Baillieres Clin Endocrinol Metab (1994) 0.87
Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial. Antivir Ther (1997) 0.87
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group. J Acquir Immune Defic Syndr (2000) 0.87
Co-Release of GABA Does Not Occur at Glycinergic Synapses onto Lumbar Motoneurons in Juvenile Mice. Front Cell Neurosci (2012) 0.87
Metachronous occurrence of seminoma and Hodgkin's lymphoma in the same patient with late-onset colon cancer. J Intern Med (1994) 0.87
Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study. Am J Gastroenterol (1994) 0.87
Depth dependence of the analytical expression for the width of the point spread function (spatial resolution) in time-resolved transillumination. J Biomed Opt (2001) 0.86
Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy. Clin Infect Dis (2001) 0.86